Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Zoubida, Karim"'
Autor:
Elise Abboud, Doha Chrayteh, Nadia Boussetta, Héloise Dalle, Mariangela Malerba, Ting-Di Wu, Morgane Le Gall, Olivier Reelfs, Charareh Pourzand, Mark Mellett, Florence Assan, Hervé Bachelez, Joël Poupon, Selim Aractingi, Sophie Vaulont, Pierre Sohier, Bénédicte Oules, Zoubida Karim, Carole Peyssonnaux
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract Psoriasis is a multifactorial, chronic inflammatory skin disease with unresolved questions on its primary events. Iron overload has been described in the epidermis of psoriasis patients, but its relevance remains unknown. We found that the k
Externí odkaz:
https://doaj.org/article/d29cac6e7c934ad798dc63142501910f
Autor:
Maria Qatato, Michael Bonadonna, Gaël Palais, Alina Ertl, Gabriele Schmidt, Maria Polycarpou-Schwarz, Zoubida Karim, Bruno Galy
Publikováno v:
HemaSphere, Vol 6, Iss 3, p e693 (2022)
Externí odkaz:
https://doaj.org/article/856c9223e7c740bfa25f36d4169ac7b6
Autor:
Elisabeth Tybl, Hiromi Gunshin, Sanjay Gupta, Tomasa Barrientos, Michael Bonadonna, Ferran Celma Nos, Gael Palais, Zoubida Karim, Mayka Sanchez, Nancy C. Andrews, Bruno Galy
Publikováno v:
HemaSphere, Vol 4, Iss 5, p e459 (2020)
Externí odkaz:
https://doaj.org/article/9d7dc065e58e45ee9233bc35b0728807
Autor:
Raêd Daher, Nicolas Ducrot, Thibaud Lefebvre, Sofia Zineeddine, Jérome Ausseil, Hervé Puy, Zoubida Karim
Publikováno v:
Metabolites, Vol 12, Iss 2, p 89 (2022)
Iron absorption requires an acidic environment that is generated by the activity of the proton pump gastric H(+)/K(+)ATPase (ATP4), expressed in gastric parietal cells. However, hepcidin, the iron regulatory peptide that inhibits iron absorption, une
Externí odkaz:
https://doaj.org/article/0c1d6a3504354770a50029d71f3d9505
Autor:
Meunier Mathieu, Chloé Friedrich, Nicolas Ducrot, Johanna Zannoni, Tondeur Sylvie, Nelly Jerraya, Sophie Rousseaux, Florent Chuffart, Olivier Kosmider, Zoubida Karim, Sophie Park
Publikováno v:
Annals of Hematology
Annals of Hematology, 2022, 101 (12), pp.2633-2643. ⟨10.1007/s00277-022-04993-7⟩
Annals of Hematology, 2022, 101 (12), pp.2633-2643. ⟨10.1007/s00277-022-04993-7⟩
International audience; In low-risk myelodysplastic syndrome (LR-MDS), erythropoietin (EPO) is widely used for the treatment of chronic anemia. However, initial response to EPO has time-limited effects. Luspatercept reduces red blood cell transfusion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::717bcea9fd75544d2123b09dfa93c9de
https://doi.org/10.1007/s00277-022-04993-7
https://doi.org/10.1007/s00277-022-04993-7
Autor:
Thibaud Lefebvre, Muriel Coupaye, Marina Esposito-Farèse, Nathalie Gault, Neila Talbi, Caroline Quintin, Caroline Schmitt, Soumeya Bekri, André Bado, Hervé Puy, Simon Msika, Carole Brasse-Lagnel, Zoubida Karim
Publikováno v:
Nutrients, Vol 13, Iss 8, p 2516 (2021)
Iron deficiency with or without anemia, needing continuous iron supplementation, is very common in obese patients, particularly those requiring bariatric surgery. The aim of this study was to address the impact of weight loss on the rescue of iron ba
Externí odkaz:
https://doaj.org/article/1bfcae04a000427a856dac40e1b610f3
Autor:
Sophie Park, Olivier Kosmider, Frédéric Maloisel, Bernard Drenou, Nicolas Chapuis, Thibaud Lefebvre, Zoubida Karim, Hervé Puy, Anne Sophie Alary, Sarah Ducamp, Frédérique Verdier, Cécile Bouilloux, Alice Rousseau, Marie-Christine Jacob, Agathe Debliquis, Agnes Charpentier, Emmanuel Gyan, Bruno Anglaret, Cecile Leyronnas, Selim Corm, Borhane Slama, Stephane Cheze, Kamel Laribi, Shanti Amé, Christian Rose, Florence Lachenal, Andrea Toma, Gian Matteo Pica, Martin Carre, Frédéric Garban, Clara Mariette, Jean-Yves Cahn, Mathieu Meunier, Olivier Herault, Pierre Fenaux, Orianne Wagner-Ballon, Valerie Bardet, Francois Dreyfus, Michaela Fontenay
Publikováno v:
Haematologica, Vol 104, Iss 3 (2019)
Erythropoiesis-stimulating agents are generally the first line of treatment of anemia in patients with lower-risk myelodysplastic syndrome. We prospectively investigated the predictive value of somatic mutations, and biomarkers of ineffective erythro
Externí odkaz:
https://doaj.org/article/d465efe30d0a4795a3a8445ef181d7b6
Autor:
Camille Petillon, Rudolf Hergesheimer, Hervé Puy, Philippe Corcia, Patrick Vourc’h, Christian Andres, Zoubida Karim, Hélène Blasco
Publikováno v:
Frontiers in Neuroscience, Vol 12 (2019)
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease caused by the loss of motor neurons. Its etiology remains unknown, but several pathophysiological mechanisms are beginning to explain motor neuronal death, as well as oxidative stress
Externí odkaz:
https://doaj.org/article/038401364462491684360abade053617
Autor:
Gérald Le Gac, Virginie Scotet, Isabelle Gourlaouen, Carine L'Hostis, Marie‐Christine Merour, Zoubida Karim, Yves Deugnier, Edouard Bardou‐Jacquet, Thibaud Lefebvre, Suzanne Assari, Claude Ferec
Publikováno v:
Alimentary Pharmacology and Therapeuthics
Alimentary Pharmacology and Therapeuthics, 2022, 55 (8), pp.1016-1027. ⟨10.1111/apt.16775⟩
Alimentary Pharmacology and Therapeuthics, 2022, 55 (8), pp.1016-1027. ⟨10.1111/apt.16775⟩
International audience; Background: Venesection is the key therapy in haemochromatosis, but it remains controversial in hyperferritinaemia with moderate iron accumulation. There is substantial evidence that the results of HFE genotyping are routinely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f7875f20d8799b90035d1b871299eb8
https://doi.org/10.1111/apt.16775
https://doi.org/10.1111/apt.16775
Autor:
Jérôme Lamoril, Dimitri Tchernitchko, Robert J. Desnick, Charles J. Parker, Hervé Puy, Laurent Gouya, Brenden Chen, Zoubida Karim, Gaël Nicolas, Colin P. Farrell, John D. Phillips
Publikováno v:
Blood Advances
Blood Advances, The American Society of Hematology, 2021, ⟨10.1182/bloodadvances.2021005484⟩
Blood Advances, The American Society of Hematology, 2021, ⟨10.1182/bloodadvances.2021005484⟩
The Mendelian inheritance pattern of acute intermittent porphyria, hereditary coproporphyria, and variegate porphyria is autosomal dominant, but the clinical phenotype is heterogeneous. Within the general population, penetrance is low, but among firs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::753451bc93ec27ff7add75d9ba25f4de
https://doi.org/10.1182/bloodadvances.2021005484
https://doi.org/10.1182/bloodadvances.2021005484